SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-004648
Filing Date
2019-03-22
Accepted
2019-03-22 06:30:35
Documents
3
Period of Report
2019-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k032119_bisoncapital.htm 8-K 27422
2 AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION f8k032119ex3-1_bison.htm EX-3.1 262466
3 AMENDMENT NO. 1 TO TRUST AGREEMENT, DATED MARCH 21, 2019, BY AND BETWEEN BISON C f8k032119ex10-1_bison.htm EX-10.1 32935
  Complete submission text file 0001213900-19-004648.txt   324302
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
Bison Capital Acquisition Corp. (Filer) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38120 | Film No.: 19698352
SIC: 2834 Pharmaceutical Preparations